| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6249dfbf3a59b03bea404b7ed958ddb7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
2020-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7816da2e513243fa53b8a61550efc9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7587527e16cb0967f6445ca91b82ebe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001c2c762a679eeac19a6b5e39c64758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8825524f11d39c73fe34c673244d224b |
| publicationDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020316165-A1 |
| titleOfInvention |
Method for treating ocular diseases |
| abstract |
The present invention provides a method for treating an ocular disease such as age-related macular degeneration (AMD), diabetic retinopathy (DR) or macular edema (ME), which comprises administering to a subject in need thereof a composition comprising a therapeutically effective amount of beauvericin. |
| priorityDate |
2019-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |